Luciana Kase Tanno

ORCID: 0000-0003-3236-1225
Publications
Citations
Views
---
Saved
---
About
Contact & Profiles
Research Areas
  • Food Allergy and Anaphylaxis Research
  • Allergic Rhinitis and Sensitization
  • Drug-Induced Adverse Reactions
  • Asthma and respiratory diseases
  • Eosinophilic Esophagitis
  • Contact Dermatitis and Allergies
  • Urticaria and Related Conditions
  • Respiratory and Cough-Related Research
  • Pharmaceutical studies and practices
  • Pharmacovigilance and Adverse Drug Reactions
  • Mast cells and histamine
  • Dermatology and Skin Diseases
  • Inhalation and Respiratory Drug Delivery
  • Autoimmune Bullous Skin Diseases
  • Medical Research and Practices
  • Olfactory and Sensory Function Studies
  • Coagulation, Bradykinin, Polyphosphates, and Angioedema
  • Health, Nursing, Elderly Care
  • Biosimilars and Bioanalytical Methods
  • Pharmacological Effects and Toxicity Studies
  • Pharmacogenetics and Drug Metabolism
  • linguistics and terminology studies
  • Biomedical and Chemical Research
  • Vaccine Coverage and Hesitancy
  • Patient-Provider Communication in Healthcare

Centre Hospitalier Universitaire de Montpellier
2016-2025

Inserm
2018-2025

Université de Montpellier
2016-2025

Hôpital Arnaud de Villeneuve
2016-2025

Hospital Sírio-Libanês
2015-2024

Sorbonne Université
2015-2024

Institut Universitaire de Recherche Clinique
2020-2024

University of Edinburgh
2023

World Health Organization - Pakistan
2018-2022

World Health Organization
2018-2022

Anaphylaxis is the most severe clinical presentation of acute systemic allergic reactions. The occurrence anaphylaxis has increased in recent years, and subsequently, there a need to continue disseminating knowledge on diagnosis management, so every healthcare professional prepared deal with such emergencies. rationale this updated position document keep guidance aligned current state art management. World Allergy Organization (WAO) guidelines were published 2011, adopts their major...

10.1016/j.waojou.2020.100472 article EN cc-by-nc-nd World Allergy Organization Journal 2020-10-01

The World Allergy Organization (WAO) Guidelines for the assessment and management of anaphylaxis provide a unique global perspective on this increasingly common, potentially life-threatening disease. Recommendations made in original WAO Anaphylaxis remain clinically valid relevant, are widely accessed frequently cited resource. In 2015 update evidence supporting recommendations Guidelines, new information based publications from January 2014 through mid- is summarized. Advances epidemiology,...

10.1186/s40413-015-0080-1 article EN cc-by-nc-nd World Allergy Organization Journal 2015-01-01

The WAO Anaphylaxis Committee present to our global colleagues the above definition and clinical criteria for diagnosis of anaphylaxis, aim being better capture reality anaphylaxis presentations, simplify therefore improve management anaphylaxis.

10.1016/j.waojou.2019.100066 article EN cc-by-nc-nd World Allergy Organization Journal 2019-10-01

<h2>Abstract</h2> Precision allergy molecular diagnostic applications (PAMD@) is increasingly entering routine care. Currently, more than 130 allergenic molecules from 50 sources are commercially available for <i>in</i> <i>vitro</i> specific immunoglobulin E (sIgE) testing. Since the last publication of this consensus document, a great deal new information has become regarding topic, with over 100 publications in year alone. It thus seems quite reasonable to publish an update. imperative...

10.1016/j.waojou.2019.100091 article EN cc-by-nc-nd World Allergy Organization Journal 2020-02-01

Abstract Background Undernotification is well recognized as a key challenge to the study of anaphylaxis mortality, but it seldom mentioned that one its reasons difficult coding condition under tenth revision international classification diseases ( ICD ‐10), given there are no anaphylaxis‐specific ‐10, which considered valid for underlying causes‐of‐death, and official mortality statistics consider exclusively disregard contributing causes‐of‐death data recorded on death certificates....

10.1111/j.1398-9995.2012.02829.x article EN Allergy 2012-04-23

Non-steroidal anti-inflammatory drugs (NSAIDs) are commonly used in the pediatric population as antipyretics/analgesics and medications. Hypersensitivity (HS) reactions to NSAID this age group, while similar adults, have unique diagnostic management issues. Although slowly accumulating, published data group still relatively rare lacking a unifying consensus. This work is summary of current knowledge consensus recommendations utilizing both expert opinion from European Network Drug Allergy...

10.1111/pai.12915 article EN Pediatric Allergy and Immunology 2018-04-25

There is a lack of consensus over the description and severity assignment allergic adverse reactions to immunotherapy, although there seems be at least in terms using World Allergy Organization (WAO) grading systems describe local events for Sublingual Immunotherapy (SLIT) Systemic Allergic Reactions (SARs) Subcutaneous (SCIT) amongst major national/regional allergy societies. In this manuscript, we propose modification previous WAO Grading system SARs, which aligns with newly-proposed...

10.1016/j.waojou.2024.100876 article EN cc-by World Allergy Organization Journal 2024-02-10

Visual Analogue Scale (VAS) is a validated tool to assess control in allergic rhinitis patients.The aim of this study was validate the use VAS MASK-rhinitis (MACVIA-ARIA Sentinel NetworK for rhinitis) app (Allergy Diary) on smartphones screens evaluate symptoms and disease control.Each user filled 4 different measuring overall, nasal, ocular, asthma at least once. Following COSMIN guidelines, we evaluated internal consistency, (Cronbach's alpha coefficient test-retest), reliability...

10.1111/cea.13025 article EN Clinical & Experimental Allergy 2017-09-08

Antibiotics are used extensively in the treatment of various infections. Consequently, they can be considered among most important agents involved adverse reactions to drugs, including both allergic and non-allergic drug hypersensitivity [J Allergy Clin Immunol 113:832-836, 2004]. Most studies published date deal mainly with beta-lactam group, information on each other antimicrobial is scarce. The present document has been produced by Special Committee Drug World Organization relevant...

10.1186/1939-4551-6-18 article EN cc-by-nc-nd World Allergy Organization Journal 2013-01-01

Abstract Objective Little is known regarding food anaphylaxis in infancy. We aimed to describe specificities of infants (≤12 months) as compared preschool children (1‐6 years). Methods conducted a retrospective study all cases recorded by the Allergy Vigilance Network from 2002 2018, focusing on infants. Results Of 1951 reactions, 61 (3%) occurred and 386 (20%) children. Two had two reactions; thus, we analyzed data among 59 (male: 51%; mean age: 6 months [SD: 2.9]); 31% history atopic...

10.1111/cea.13519 article EN Clinical & Experimental Allergy 2019-10-25

Perioperative anaphylaxis (PA) is a severe condition that can be fatal, but data on PA mortality are scarce. The aim of this article to review the epidemiology, elicitors and risk factors for identify knowledge gaps areas improvement regarding management PA. affects about 100 cases per million procedures. Mortality rare, estimated at 3 5 procedures, rate higher than other aetiologies, 1.4% 4.8%. However, incomplete. Published mention neuromuscular blocking agents antibiotics, mainly...

10.1111/cea.14434 article EN cc-by-nc-nd Clinical & Experimental Allergy 2024-01-01
Coming Soon ...